Powerful Single Cell Bioinformatics Solution in a Graphical User Interface
ST. LOUIS and CAMBRIDGE — 1/24/2019 — 1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize advanced Partek statistical and visualization tools for characterizing individual cells. In addition, users developing their own custom inDrop applications can take advantage of the wide variety of single cell bioinformatics tools available in the software and configure them using an intuitive interface.
cell analysis is growing in popularity within the life science community and provides
exciting, novel insights into biological processes and diseases. It can be used
in a wide variety of applications including tumor profiling, validation of drug
targets, identification of cell-to-cell variation, and developmental lineage
tracing. However, bioinformatics analysis remains a roadblock for many researchers.
Traditional solutions require advanced computational skills or in-house informatics
capabilities. Partek Flow solves this problem by enabling scientists to easily analyze
their scRNA-Seq data with an intuitive point-and-click interface.
When asked about the partnership, Tom Downey,
President of Partek said, “We are excited to work with 1CellBio to deliver an
affordable and easy-to-use solution for analyzing single cell data, enabling
scientists to ask and answer their own research questions without needing to
learn and use command line tools”.
“We are delighted to partner with Partek,” said Colin J.H. Brenan, PhD, Chief Executive Officer, 1CellBio. “Not only do they offer the best in class scRNA-seq analysis solution today, but their continued innovation will meet our needs as we introduce additional single cell applications.”
You can watch a demonstration of the Partek Flow 1CellBio analysis pipeline in a joint webinar coming soon. Sign up for webinar notifications to receive information about this webinar once available.
Inc. is the leading single-cell analysis company serving the biomedical research
community. The company’s flagship inDrop™ System, a high-resolution,
single-cell transcriptomics platform, delivers greater experimental control,
rare actionable information and lower overall cost per result compared to all
other existing platforms. Research laboratories around the world are now
adopting the platform for a wide range of single-cell applications from tumor
profiling to stem cells to embryo development to the identification and
validation of new drug targets. Founded by leading scientists at Harvard
University, 1CellBio is based in Cambridge, MA, and the company supports its
growing number of customers through a team of international sales and field
application scientists. For more information, please visit www.1cell-bio.com.